PSNPrescribable
amivantamab-lpuj 1600 MG / hyaluronidase-lpuj 20000 UNT in 10 ML Injection
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Rybrevant Faspro Injection
RxNorm Crosswalk NDC 57894-522
View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC
RxNorm Mapping Clinical Concepts
This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
The product Rybrevant Faspro (NDC 57894-522) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 8 unique RxNorm concepts. By anchoring Janssen Biotech, Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
SCDPrescribable
Featured Concept
10 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection
(RxCUI 2729297)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Rybrevant Faspro 1600 MG / 20000 UNT in 10 ML Injection
(RxCUI 2729304)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
14 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection
(RxCUI 2729306)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Rybrevant Faspro 2240 MG / 28000 UNT in 14 ML Injection
(RxCUI 2729307)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
15 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection
(RxCUI 2735796)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Rybrevant Faspro 2400 MG / 30000 UNT in 15 ML Injection
(RxCUI 2735797)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
SCDPrescribable
Featured Concept
22 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection
(RxCUI 2735803)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Rybrevant Faspro 3520 MG / 44000 UNT in 22 ML Injection
(RxCUI 2735804)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
Understanding RxNorm Mapping for Rybrevant Faspro
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 57894-522 to RxCUI 2729297, 2729304, 2729306, 2729307, 2735796, 2735797, 2735803, 2735804, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
- PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
- SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
- SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
- SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
* Please review the full disclaimer at the bottom of this page.
